Interference with formation and expression of RNA tumor virus information: rationale and experimental results.
D000818:Animals; D002471:Cell Transformation, Neoplastic; D004254:DNA Nucleotidyltransferases / Q000378:metabolism; D004261:DNA Replication; D004279:DNA, Viral / Q000378:metabolism*; D004317:Doxorubicin / Q000494:pharmacology; D007700:Kinetics; D007938:Leukemia / Q000097:blood / Q000175:diagnosis / Q000201:enzymology / Q000382:microbiology; D007942:Leukemia, Experimental / Q000517:prevention & control; D009369:Neoplasms / Q000382:microbiology; D009858:Oncogenic Viruses / Q000201:enzymology / Q000378:metabolism*; D012328:RNA Viruses / Q000378:metabolism*; D012367:RNA, Viral / Q000378:metabolism*; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism*; D012190:Retroviridae / Q000378:metabolism; D018894:Reverse Transcriptase Inhibitors; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use; D014158:Transcription, Genetic; D014779:Virus Replication
D004279:DNA, Viral; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors; D004317:Doxorubicin; D004254:DNA Nucleotidyltransferases; D012194:RNA-Directed DNA Polymerase; D012293:Rifampin